Soft Tissue Sarcoma Competitive Landscape Analysis 2024: 361 Molecules in the Pipeline, Including 10 Drugs in the Late-stage Pipeline with Roche, BMS, Novartis, and Boehringer Ingelheim Leading
31 juil. 2024 10h50 HE
|
Research and Markets
Dublin, July 31, 2024 (GLOBE NEWSWIRE) -- The "Soft Tissue Sarcoma: Competitive Landscape" report has been added to ResearchAndMarkets.com's offering. This report provides a data-driven...
Ewing Sarcoma Drug Pipeline Market Research 2024: Insights About 25+ Companies and 25+ Pipeline Drugs
19 avr. 2024 07h22 HE
|
Research and Markets
Dublin, April 19, 2024 (GLOBE NEWSWIRE) -- The "Ewing Sarcoma - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This "Ewing Sarcoma - Pipeline Insight,...
Ewing Sarcoma Global Clinical Trials Review 2024
02 avr. 2024 09h40 HE
|
Research and Markets
Dublin, April 02, 2024 (GLOBE NEWSWIRE) -- The "Ewing Sarcoma - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.The clinical trial report...